VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for YAG laser capsulotomy after surgery, our device has the potential to revolutionise cataract surgery in both the human and veterinary markets.
Location: United Kingdom, England
Employees: 1-10
Investors 3
| Date | Name | Website |
| - | Innvotec | innvotec.c... |
| - | MassChalle... | masschalle... |
| - | London Co-... | lcif.co |
Mentions in press and media 1
| Date | Title | Description |
| 16.05.2019 | MassChallenge Switzerland Announces its 4th Startup Cohort | May 15, 2019 Renens – MassChallenge Switzerland, part of MassChallenge’s global network of zero-equity startup accelerators, today announced the 76 early-stage, high-impact startups accepted into its 2019 accelerator. These startups repres... |